What are the side effects of Pyridostigmine (Mestinon)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pyridostigmine Side Effects

Pyridostigmine (Mestinon) commonly causes muscarinic and nicotinic side effects, with gastrointestinal symptoms being the most prevalent adverse reactions. 1

Common Side Effects

Muscarinic Side Effects

  • Gastrointestinal symptoms:
    • Nausea and vomiting
    • Diarrhea and abdominal cramps
    • Increased peristalsis
    • Flatulence 2
  • Increased secretions:
    • Excessive salivation
    • Increased bronchial secretions
    • Hyperhidrosis (excessive sweating)
  • Urinary symptoms:
    • Urinary urgency
    • Urinary incontinence 3, 1
  • Visual changes:
    • Miosis (pupil constriction)
    • Blurred vision 2

Nicotinic Side Effects

  • Neuromuscular symptoms:
    • Muscle cramps and fasciculations
    • Muscle weakness
    • Muscle twitching 1, 2

Frequency and Severity

The prevalence of side effects is remarkably high, with studies showing that up to 91% of patients using pyridostigmine report at least one side effect 2. The most commonly reported side effects in clinical practice include:

  1. Flatulence
  2. Urinary urgency
  3. Muscle cramps
  4. Blurred vision
  5. Hyperhidrosis 2

Serious Adverse Effects

Cholinergic Crisis

Overdosage of pyridostigmine can result in cholinergic crisis, characterized by:

  • Progressive muscle weakness
  • Respiratory muscle involvement that may lead to respiratory failure
  • Potentially fatal if not recognized and treated promptly 1

This is particularly important to distinguish from myasthenic crisis (worsening of the underlying condition), as the treatments are opposite - cholinergic crisis requires withdrawal of pyridostigmine while myasthenic crisis requires increased dosage 1.

Management of Side Effects

  1. Dose adjustment: Many side effects are dose-related and can be managed by careful dose titration 4

  2. Atropine administration: Muscarinic side effects can be counteracted with atropine, though this should be used cautiously 1

  3. Timing of medication: Taking pyridostigmine with food may reduce gastrointestinal side effects 3

  4. Discontinuation: In cases of severe side effects or cholinergic crisis, prompt withdrawal of the medication is necessary 1

Special Populations

  • Pregnancy: Safety during pregnancy has not been established; use requires weighing potential benefits against possible risks to mother and child 1

  • Elderly patients: May be more susceptible to side effects and should start with lower doses 5

  • Patients with autonomic dysfunction: May experience more pronounced cardiovascular effects 5

Clinical Pearls

  • Diarrhea, abdominal cramps, and muscle twitching are the most frequently cited reasons for discontinuation of pyridostigmine 2

  • Despite side effects, many patients (58-81%) who experience clinical benefit choose to continue therapy 6

  • The clinical recovery from pyridostigmine overdose is typically faster than the spontaneous recovery of cholinesterase enzyme activity 7

  • In patients with neurogenic orthostatic hypotension, pyridostigmine may improve orthostatic tolerance through increases in peripheral vascular resistance and blood pressure 3

  • For myasthenic symptoms, pyridostigmine can be started at 30 mg orally and titrated up to 600 mg daily as needed 3

Monitoring Recommendations

  • Regular assessment of symptom improvement versus side effect burden
  • Vigilance for signs of cholinergic crisis (increasing weakness, respiratory difficulties)
  • In patients with orthostatic hypotension, monitor blood pressure in both supine and standing positions 5

Understanding these side effects and their management is crucial for optimizing treatment outcomes and ensuring patient safety when prescribing pyridostigmine.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Autonomic Dysfunction Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acute pyridostigmine overdose: a report of nine cases.

Israel journal of medical sciences, 1991

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.